MENU
+Compare
ACRV
Stock ticker: NASDAQ
AS OF
Sep 24, 04:59 PM (EDT)
Price
$1.55
Change
-$0.03 (-1.90%)
Capitalization
49.7M

ACRV Acrivon Therapeutics Forecast, Technical & Fundamental Analysis

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform... Show more

ACRV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ACRV with price predictions
Sep 23, 2025

ACRV's RSI Oscillator leaves overbought zone

The 10-day RSI Oscillator for ACRV moved out of overbought territory on September 09, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 15 instances where the indicator moved out of the overbought zone. In of the 15 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 22, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ACRV as a result. In of 56 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ACRV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ACRV broke above its upper Bollinger Band on September 08, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 43 cases where ACRV's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ACRV just turned positive on September 08, 2025. Looking at past instances where ACRV's MACD turned positive, the stock continued to rise in of 20 cases over the following month. The odds of a continued upward trend are .

ACRV moved above its 50-day moving average on September 05, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ACRV crossed bullishly above the 50-day moving average on August 18, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 7 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ACRV advanced for three days, in of 147 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 73 cases where ACRV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.347) is normal, around the industry mean (19.924). P/E Ratio (0.000) is within average values for comparable stocks, (54.318). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.126). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (347.892).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ACRV’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ACRV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ACRV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ACRV is expected to report earnings to rise 110.91% to -115 cents per share on November 06

Acrivon Therapeutics ACRV Stock Earnings Reports
Q3'25
Est.
$-1.16
Q2'25
Beat
by $0.54
Q1'25
Beat
by $0.50
Q4'24
Beat
by $0.17
Q3'24
Beat
by $0.15
The last earnings report on August 13 showed earnings per share of -55 cents, beating the estimate of -109 cents. With 107.18K shares outstanding, the current market capitalization sits at 49.70M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
480 Arsenal Way
Phone
+1 617 207-8979
Employees
61
Web
https://www.acrivon.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BEAG10.450.05
+0.48%
Bold Eagle Acquisition Corp
MTPVY15.00N/A
N/A
Metropole Television SA
ADDHY17.30N/A
N/A
Addtech AB
GO15.28-0.32
-2.05%
Grocery Outlet Holding Corp
WIMI4.97-0.16
-3.12%
WiMi Hologram Cloud Inc

ACRV and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ACRV has been loosely correlated with ALLR. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ACRV jumps, then ALLR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACRV
1D Price
Change %
ACRV100%
-4.82%
ALLR - ACRV
46%
Loosely correlated
-10.11%
AURA - ACRV
40%
Loosely correlated
+0.97%
LXEO - ACRV
39%
Loosely correlated
+0.75%
XNCR - ACRV
36%
Loosely correlated
-0.67%
HUMA - ACRV
36%
Loosely correlated
-3.95%
More